Socioeconomic Status and Adherence to Preventive Measures During the COVID-19 Pandemic in Switzerland: A Population Based Digital Cohort Analysis.


Journal

International journal of public health
ISSN: 1661-8564
Titre abrégé: Int J Public Health
Pays: Switzerland
ID NLM: 101304551

Informations de publication

Date de publication:
2024
Historique:
received: 17 11 2023
accepted: 12 06 2024
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 18 7 2024
Statut: epublish

Résumé

To assess the association between socioeconomic status (SES) and self-reported adherence to preventive measures in Switzerland during the COVID-19 pandemic. 4,299 participants from a digital cohort were followed between September 2020 and November 2021. Baseline equivalised disposable income and education were used as SES proxies. Adherence was assessed over time. We investigated the association between SES and adherence using multivariable mixed logistic regression, stratifying by age (below/above 65 years) and two periods (before/after June 2021, to account for changes in vaccine coverage and epidemiological situation). Adherence was high across all SES strata before June 2021. After, participants with higher equivalised disposable income were less likely to adhere to preventive measures compared to participants in the first (low) quartile [second (Adj.OR, 95% CI) (0.56, 0.37-0.85), third (0.38, 0.23-0.64), fourth (0.60, 0.36-0.98)]. We observed similar results for education. No differences by SES were found during the period with high SARS-CoV-2 incidence rates and stringent measures. Following the broad availability of vaccines, lower incidence, and eased measures, differences by SES started to emerge. Our study highlights the need for contextual interpretation when assessing SES impact on adherence to preventive measures.

Identifiants

pubmed: 39022447
doi: 10.3389/ijph.2024.1606861
pii: 1606861
pmc: PMC11251880
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1606861

Informations de copyright

Copyright © 2024 Tancredi, van der Linden, Chiolero, Cullati, Imboden, Probst-Hensch, Keidel, Witzig, Dratva, Michel, Harju, Frank, Lorthe, Baysson, Stringhini, Kahlert, Bardoczi, Haller, Chocano-Bedoya, Rodondi, Amati, Albanese, Corna, Crivelli, Kaufmann, Frei and von Wyl.

Déclaration de conflit d'intérêts

The authors declare that they do not have any conflicts of interest.

Auteurs

Stefano Tancredi (S)

Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland.

Bernadette W A van der Linden (BWA)

Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland.

Arnaud Chiolero (A)

Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland.
School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
Institute of Primary Healthcare (BIHAM), University of Bern, Bern, Switzerland.

Stéphane Cullati (S)

Population Health Laboratory (#PopHealthLab), University of Fribourg, Fribourg, Switzerland.
Quality of Care Service, Geneva University Hospitals, Geneva, Switzerland.

Medea Imboden (M)

Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Nicole Probst-Hensch (N)

Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Dirk Keidel (D)

Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Melissa Witzig (M)

Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
University of Basel, Basel, Switzerland.

Julia Dratva (J)

University of Basel, Basel, Switzerland.
Zurich University of Applied Sciences, Winterthur, Switzerland.

Gisela Michel (G)

Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.

Erika Harju (E)

Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
School of Health Sciences, ZHAW Zurich University of Applied Sciences, Winterthur, Switzerland.

Irene Frank (I)

Clinical Trial Unit, Cantonal Hospital Lucerne, Lucerne, Switzerland.

Elsa Lorthe (E)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Université Paris Cité, INSERM, INRAE, Centre for Research in Epidemiology and Statistics Paris (CRESS), Paris, France.

Hélène Baysson (H)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.

Silvia Stringhini (S)

Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
University Center of General Medicine and Public Health, Lausanne, Switzerland.
School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

Christian R Kahlert (CR)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.
Children's Hospital of Eastern Switzerland, Department of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Julia B Bardoczi (JB)

Institute of Primary Healthcare (BIHAM), University of Bern, Bern, Switzerland.
Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Moa Lina Haller (ML)

Institute of Primary Healthcare (BIHAM), University of Bern, Bern, Switzerland.

Patricia O Chocano-Bedoya (PO)

Institute of Primary Healthcare (BIHAM), University of Bern, Bern, Switzerland.

Nicolas Rodondi (N)

Institute of Primary Healthcare (BIHAM), University of Bern, Bern, Switzerland.
Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Rebecca Amati (R)

Institute of Public Health, Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.

Emiliano Albanese (E)

Institute of Public Health, Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.

Laurie Corna (L)

Department of Business Economics, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland, Manno, Switzerland.

Luca Crivelli (L)

Institute of Public Health, Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.
Department of Business Economics, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland, Manno, Switzerland.

Marco Kaufmann (M)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Anja Frei (A)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Viktor von Wyl (V)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH